Binkui Li

4.1k total citations · 1 hit paper
103 papers, 2.8k citations indexed

About

Binkui Li is a scholar working on Hepatology, Molecular Biology and Oncology. According to data from OpenAlex, Binkui Li has authored 103 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hepatology, 32 papers in Molecular Biology and 31 papers in Oncology. Recurrent topics in Binkui Li's work include Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (22 papers) and Liver Disease Diagnosis and Treatment (22 papers). Binkui Li is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (22 papers) and Liver Disease Diagnosis and Treatment (22 papers). Binkui Li collaborates with scholars based in China, United States and Hong Kong. Binkui Li's co-authors include Yunfei Yuan, Yun Zheng, Jiliang Qiu, Wei He, Pinzhu Huang, Ruhai Zou, Jian Hong, Xin‐Yuan Guan, Dan Xie and Yuanping Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Binkui Li

99 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

2023 71 citations Yichuan Yuan, Wei He et al. International Journal of Surgery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Binkui Li China	30	1.3k	950	932	743	519	103	2.8k
Guo‐Ming Shi China	30	1.8k 1.4×	1.2k 1.3×	483 0.5×	740 1.0×	293 0.6×	71	3.0k
Camilla Pilati France	19	1.1k 0.9×	617 0.6×	542 0.6×	1.1k 1.5×	373 0.7×	32	2.7k
Annarita Destro Italy	29	1.2k 0.9×	621 0.7×	853 0.9×	1.5k 2.0×	523 1.0×	58	3.7k
Naoki Ikenaga Japan	25	830 0.6×	502 0.5×	507 0.5×	962 1.3×	458 0.9×	75	2.3k
Francesco Galimi Italy	24	1.1k 0.9×	458 0.5×	738 0.8×	1.2k 1.6×	154 0.3×	35	2.5k
Xin‐Da Zhou China	27	678 0.5×	497 0.5×	1.5k 1.6×	541 0.7×	672 1.3×	61	2.5k
Jiliang Qiu China	21	525 0.4×	404 0.4×	655 0.7×	345 0.5×	351 0.7×	65	1.5k
Ludwig Wilkens Germany	27	1.2k 0.9×	495 0.5×	331 0.4×	575 0.8×	247 0.5×	77	2.5k
Rin Yamaguchi Japan	25	465 0.4×	624 0.7×	360 0.4×	963 1.3×	236 0.5×	100	2.1k
Belinda Cancilla United States	18	1.5k 1.2×	377 0.4×	347 0.4×	1.1k 1.5×	242 0.5×	38	2.7k

Countries citing papers authored by Binkui Li

Since Specialization

Citations

This map shows the geographic impact of Binkui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binkui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binkui Li more than expected).

Fields of papers citing papers by Binkui Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binkui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binkui Li. The network helps show where Binkui Li may publish in the future.

Co-authorship network of co-authors of Binkui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Binkui Li. A scholar is included among the top collaborators of Binkui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binkui Li. Binkui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Liangcai, Binkui Li, Yun Fan, et al.. (2025). 66P: Long-term follow-up of limertinib (ASK120067) in patients with locally advanced or metastatic EGFR T790M NSCLC: A multicentre, single-arm, phase IIb study. Journal of Thoracic Oncology. 20(3). S51–S52. 1 indexed citations

Zhu, Xiao‐Dong, et al.. (2025). Systemic Treatment for Unresectable Hepatocellular Carcinoma: A Surgeon’s Perspective. Journal of Hepatocellular Carcinoma. Volume 12. 399–413.

Shi, Yunxing, Kai Li, Yichuan Yuan, et al.. (2024). Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma. Cancer Cell International. 24(1). 138–138. 2 indexed citations

Wang, De‐Shen, Chao Ren, Tianqi Zhang, et al.. (2024). Safety and efficacy of adjuvant FOLFOX/FOLFIRI with versus without hepatic arterial infusion of floxuridine in patients following colorectal cancer liver metastasectomy (HARVEST trial): A randomized controlled trial. European Journal of Cancer. 214. 115154–115154. 3 indexed citations

Li, Huifang, Ming Shi, Pinzhu Huang, et al.. (2024). Contrast-enhanced intraoperative ultrasound improved hepatic recurrence-free survival in initially unresectable colorectal cancer liver metastases. Digestive and Liver Disease. 57(2). 467–476. 2 indexed citations

Chen, Tiejun, Wenbin Li, Wei He, et al.. (2024). Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort study. International Immunopharmacology. 139. 112711–112711. 10 indexed citations

Li, Yuan, Cheng Feng, Hao Wang, et al.. (2024). An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis. International Journal of Clinical Oncology. 29(9). 1263–1273. 2 indexed citations

Yuan, Yichuan, Xiaozhong Peng, Wei He, et al.. (2024). Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial. Cancer Communications. 44(11). 1337–1349. 2 indexed citations

Bi, Fangfang, et al.. (2023). METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition. Cell Death Discovery. 9(1). 428–428. 13 indexed citations

10.

Yuan, Yichuan, Wei He, Jiliang Qiu, et al.. (2023). TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study. International Journal of Surgery. 109(5). 1222–1230. 71 indexed citations breakdown →

11.

Jiang, Lingmin, Wei He, Jiliang Qiu, et al.. (2022). More Liver Metastases Detected Intraoperatively Indicates Worse Prognosis for Colorectal Liver Metastases Patients after Resection Combined with Microwave Ablation. Journal of Oncology. 2022. 1–8. 2 indexed citations

12.

Li, Kai, Yi Niu, Yichuan Yuan, et al.. (2022). Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling. Oncogene. 41(23). 3197–3209. 13 indexed citations

13.

Zhang, Yuanping, Wei He, Chuan Peng, et al.. (2021). Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy alone. International Journal of Hyperthermia. 38(1). 372–381. 4 indexed citations

14.

Liang, Jie‐Ying, Haocheng Lin, Jingwen Liu, et al.. (2021). A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy. Cancer Medicine. 10(5). 1535–1544. 10 indexed citations

15.

Liu, Wenwu, Ruhai Zou, Chenwei Wang, et al.. (2019). Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis. Therapeutic Advances in Medical Oncology. 11. 3862489692–3862489692. 27 indexed citations

16.

Wang, Yun, Zhiqiang Wang, Feng-Hua Wang, et al.. (2017). The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?. Journal of Cancer. 8(7). 1179–1186. 17 indexed citations

17.

Qiu, Jiliang, Yun Zheng, Jingxian Shen, et al.. (2015). Resection versus ablation in hepatitis B virus−related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study. Surgery. 158(5). 1235–1243. 14 indexed citations

18.

Hong, Jian, Yunfei Yuan, Jianping Wang, et al.. (2014). Expression of Variant Isoforms of the Tyrosine Kinase SYK Determines the Prognosis of Hepatocellular Carcinoma. Cancer Research. 74(6). 1845–1856. 37 indexed citations

19.

Wei, Rongrong, Guoliang Huang, Mei-Yin Zhang, et al.. (2013). Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma. Clinical Cancer Research. 19(17). 4780–4791. 88 indexed citations

20.

Huang, Pinzhu, Li Wang, Jian Hong, et al.. (2012). LIN28 expression and prognostic value in hepatocellular carcinoma patients who meet the Milan criteria and undergo hepatectomy. Chinese Journal of Cancer. 31(5). 223–232. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact